MedTrace Logo

The Jetstream G3™ Calcium Study

NCT01273623 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2015-11-18

Study results available
· View outcomes & findings →

Summary

To investigate the treatment effects with the Jetstream G3 System in moderate to severely calcified peripheral artery disease in the common femoral, superficial femoral or popliteal arteries using intravascular ultrasound (IVUS).

Conditions

  • Peripheral Arterial Disease

Interventions

DEVICE

Jetstream Atherectomy System

to perform atherectomy on calcified lesions

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • Tom Davis, MD · St. John Hospital

  • Malcolm Foster · Mercy Medical Center

  • Venkatesh Ramaiah, MD · Arizona Heart Institute

  • Joseph Ricotta, MD · Emory University

  • Thomas Shimshak, MD · Wheaton Franciscan Healthcare

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2012-03-31
Completion
2012-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01273623 on ClinicalTrials.gov